Absci Investigates Novel Treatments for Genetic Hair Loss and Endometriosis: Phase 1/2a Clinical Trial Update
Absci Corporation, a generative AI-powered drug discovery company, has seen its stock price climb significantly since the start of 2024, reflecting investor interest in its expanding clinical pipeline. As of recent market observations, the company’s valuation has experienced a notable upward trajectory, driven largely by its efforts to leverage artificial intelligence in the identification and … Read more